Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 29, 2015
Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal MetastasesPradeep Thapa, Dilip Nikam, Tapas Das, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 10, 2017
Preparation of clinical-scale 177 Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulationMohini Guleria, Tapas Das, Chandan Kumar, et al.
Nuclear Medicine and Biology|May 25, 2006
175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small jointsSudipta Chakraborty, Tapas Das, Sharmila Banerjee, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 13, 2013
Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acidsKusum Vats, Tapas Das, Haladhar D Sarma, et al.
Biomed Research International|August 11, 2020
Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with 177Lu-AcridineSubhajit Ghosh, Tapas Das, Shishu K Suman, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 21, 2018
177 Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell lineChandan Kumar, Rohit Sharma, Tapas Das, et al.
In Vitro Cellular & Developmental Biology. Animal|May 20, 2016
In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubesKamran A Mirza, Menghua Luo, Suzette Pereira, et al.
Bioorganic Chemistry|August 16, 2023
Design, synthesis and evaluation of 177Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpressionAmit Kumar Sharma, Rohit Sharma, Haladhar Dev Sarma, et al.
Pageof 14